318 related articles for article (PubMed ID: 26276667)
1. Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.
Ricciardi MR; Mirabilii S; Allegretti M; Licchetta R; Calarco A; Torrisi MR; Foà R; Nicolai R; Peluso G; Tafuri A
Blood; 2015 Oct; 126(16):1925-9. PubMed ID: 26276667
[TBL] [Abstract][Full Text] [Related]
2. Targeting leukemia's "fatty tooth".
Samudio I; Konopleva M
Blood; 2015 Oct; 126(16):1874-5. PubMed ID: 26472736
[TBL] [Abstract][Full Text] [Related]
3. Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.
Pacilli A; Calienni M; Margarucci S; D'Apolito M; Petillo O; Rocchi L; Pasquinelli G; Nicolai R; Koverech A; Calvani M; Peluso G; Montanaro L
J Natl Cancer Inst; 2013 Apr; 105(7):489-98. PubMed ID: 23486551
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.
Mao S; Ling Q; Pan J; Li F; Huang S; Ye W; Wei W; Lin X; Qian Y; Wang Y; Huang X; Huang J; Wang J; Jin J
J Transl Med; 2021 Apr; 19(1):181. PubMed ID: 33926484
[TBL] [Abstract][Full Text] [Related]
5. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
6. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
7. Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
Sung GJ; Choi HK; Kwak S; Song JH; Ko H; Yoon HG; Kang HB; Choi KC
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):76-81. PubMed ID: 27793752
[TBL] [Abstract][Full Text] [Related]
8. High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
Shi J; Fu H; Jia Z; He K; Fu L; Wang W
EBioMedicine; 2016 Dec; 14():55-64. PubMed ID: 27916548
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Wang L; Li C; Song Y; Yan Z
Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Aiderus A; Black MA; Dunbier AK
BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.
Qu Q; Zeng F; Liu X; Wang QJ; Deng F
Cell Death Dis; 2016 May; 7(5):e2226. PubMed ID: 27195673
[TBL] [Abstract][Full Text] [Related]
12. A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer.
Hu A; Wang H; Xu Q; Pan Y; Jiang Z; Li S; Qu Y; Hu Y; Wu H; Wang X
Redox Biol; 2023 Dec; 68():102959. PubMed ID: 37977042
[TBL] [Abstract][Full Text] [Related]
13. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
Schlaepfer IR; Joshi M
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
[TBL] [Abstract][Full Text] [Related]
14. Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.
Huang D; Chowdhury S; Wang H; Savage SR; Ivey RG; Kennedy JJ; Whiteaker JR; Lin C; Hou X; Oberg AL; Larson MC; Eskandari N; Delisi DA; Gentile S; Huntoon CJ; Voytovich UJ; Shire ZJ; Yu Q; Gygi SP; Hoofnagle AN; Herbert ZT; Lorentzen TD; Calinawan A; Karnitz LM; Weroha SJ; Kaufmann SH; Zhang B; Wang P; Birrer MJ; Paulovich AG
Cell Rep Med; 2021 Dec; 2(12):100471. PubMed ID: 35028612
[TBL] [Abstract][Full Text] [Related]
15. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses.
Namgaladze D; Lips S; Leiker TJ; Murphy RC; Ekroos K; Ferreiros N; Geisslinger G; Brüne B
Diabetologia; 2014 May; 57(5):1067-77. PubMed ID: 24488024
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid Oxidation Protects against Hyperoxia-induced Endothelial Cell Apoptosis and Lung Injury in Neonatal Mice.
Yao H; Gong J; Peterson AL; Lu X; Zhang P; Dennery PA
Am J Respir Cell Mol Biol; 2019 Jun; 60(6):667-677. PubMed ID: 30571144
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone.
Foxworthy PS; Eacho PI
Biochem J; 1988 Jun; 252(2):409-14. PubMed ID: 3415664
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation.
Li R; Li X; Zhao J; Meng F; Yao C; Bao E; Sun N; Chen X; Cheng W; Hua H; Li X; Wang B; Wang H; Pan X; You H; Yang J; Ikezoe T
Theranostics; 2022; 12(2):976-998. PubMed ID: 34976224
[No Abstract] [Full Text] [Related]
20. NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation.
Xu R; Liu Y; Ma L; Sun Y; Liu H; Yang Y; Jin T; Yang D
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):758-768. PubMed ID: 37249337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
